SevenBridge Financial Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-500
Closed -$4K 459
2019
Q2
$4K Buy
+500
New +$2.69K ﹤0.01% 543
2017
Q4
Sell
-600
Closed -$11K 635
2017
Q3
$11K Hold
600
0.01% 438
2017
Q2
$14K Hold
600
0.01% 420
2017
Q1
$12K Buy
600
+398
+197% +$8.88K 0.01% 419
2016
Q4
$5K Hold
202
﹤0.01% 514
2016
Q3
$5K Hold
202
﹤0.01% 504
2016
Q2
$5K Buy
+202
New +$5.73K ﹤0.01% 592

Other funds holding PGEN

SevenBridge Financial Group's PGEN Position: Q3 2019 in Review

SevenBridge Financial Group sold out of Precigen (PGEN) in Q3 2019, closing a stake of 500 shares — an estimated $4K sold.

SevenBridge Financial Group first reported a position in PGEN in Q2 2016 and held it in 7 quarters. The position peaked at $14K in Q2 2017. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2019.

  • SevenBridge Financial Group reported no remaining Precigen position as of Q3 2019 after selling out during the quarter.
  • SevenBridge Financial Group sold 500 Precigen shares in Q3 2019, an estimated $4K.
  • SevenBridge Financial Group first reported a position in Precigen in Q2 2016 and held it in 7 quarters.
  • SevenBridge Financial Group's Precigen position peaked at $14K in Q2 2017.
  • 170 funds tracked by Wall St. Rank held Precigen as of Q3 2019.

Based on SevenBridge Financial Group's 13F filing for Q3 2019, filed 9 Oct 2019.